 |
 |
|
Home |
Current Issue |
Past Issues |
In the Clinic |
ACP Journal Club |
CME |
Collections |
Audio/Video |
Mobile |
Subscribe |
Tools |
Help |
ACP Online
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
15 December 1994 | Volume 121 Issue 12 | Pages 912-918
Objective: To determine the proportion of end-stage renal disease associated with diabetes mellitus in a biracial population, using population-attributable risk estimates.
Design: Case-control study.
Setting: Population-based study in Maryland, Virginia, West Virginia, and Washington, D.C.
Participants: 716 newly treated patients with kidney failure aged 20 to 64 years and 361 age-matched controls.
Measurements: Self-reported history of diabetes mellitus, including type, duration, treatment, and complications.
Results: Persons with insulin-dependent diabetes (odds ratio, 33.7) and non-insulin-dependent diabetes (odds ratio, 7.0) were at greater risk for end-stage renal disease than were persons without diabetes. The odds ratio was only slightly increased for diabetes lasting less than 15 years, but the ratio increased more than 20-fold for diabetes lasting 15 years or more. The population-attributable risk for kidney failure was 21% for insulin-dependent diabetes and 21% for non-insulin-dependent diabetes (42% overall). A similar proportion of end-stage renal disease was attributed to diabetes in whites (44%) and in blacks (41%). Insulin-dependent diabetes had a relatively greater effect on the incidence of kidney failure in whites; in contrast, non-insulin-dependent diabetes had a relatively greater effect on kidney failure in blacks.
Conclusions: Diabetes mellitus has a major effect on the incidence of end-stage renal disease in nonelderly adults. In black persons, diabetes may be responsible for a larger proportion of end-stage renal disease than is suggested by the use of clinical diagnoses of underlying renal disease made by patients' nephrologists. Prevention of end-stage renal disease associated with diabetes mellitus (both insulin-dependent and non-insulin-dependent diabetes) requires increased attention from laboratory and clinical researchers.
Author and Article Information
From The Johns Hopkins University School of Hygiene and Public Health and School of Medicine, Baltimore, Maryland; and the University of Geneva, Geneva, Switzerland.
ARTICLE
End-Stage Renal Disease Attributable to Diabetes Mellitus
Requests for Reprints: Thomas V. Perneger, MD, PhD, Institute of Social and Preventive Medicine, University of Geneva, CMU Case Postale, 1211 Geneva 4, Switzerland.
Acknowledgments: The authors thank Shirley Kritt, Tamra Myers, and Jennifer Sykes for their technical assistance and acknowledge the contributions of collaborators at the Health Care Financing Administration (Zermain Breidenbaugh, Paul Eggers, Pamela Frederick, Michael McMullan, Paul Mendelsohn, and Izzy Oppenheimer) and the Mid-Atlantic Renal Coalition (Nancy Armistead and Arlene Skinner).
Grant Support: By grants from the Swiss National Science Foundation (823B-025121 and 32-32609), the Schmidheiny Foundation, the American Heart Association, the National Kidney Foundation, the Agency for Health Care Policy and Research (R03 HS 06978-01), GCRC grants (5MOIRR00722 and RR00035) from the National Center for Research Resources, and a Health of the Public Award from the Pew Charitable Trusts and Robert Wood Johnson Foundation. Dr. Brancati is supported by a Career Development Grant from the American Diabetes Association. Dr. Klag is an Established Investigator of the American Heart Association.
This article has been cited by other articles:
|
|
 |
|
  A. P. Hingorani, E. Ascher, and N. Marks Duplex Arteriography for Lower Extremity Revascularization Perspectives in Vascular Surgery and Endovascular Therapy, March 1, 2007; 19(1): 6 - 20. [Abstract] [PDF]
|
|
|
|
 |
|
 P. Ruggenenti, A. Perna, M. Ganeva, B. Ene-Iordache, G. Remuzzi, and for the BENEDICT Study Group Impact of Blood Pressure Control and Angiotensin-Converting Enzyme Inhibitor Therapy on New-Onset Microalbuminuria in Type 2 Diabetes: A Post Hoc Analysis of the BENEDICT Trial J. Am. Soc. Nephrol., December 1, 2006; 17(12): 3472 - 3481. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Jones, P. Roderick, S. Harris, and M. Rogerson Decline in kidney function before and after nephrology referral and the effect on survival in moderate to advanced chronic kidney disease Nephrol. Dial. Transplant., August 1, 2006; 21(8): 2133 - 2143. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Berl and W. Henrich Kidney-Heart Interactions: Epidemiology, Pathogenesis, and Treatment Clin. J. Am. Soc. Nephrol., January 1, 2006; 1(1): 8 - 18. [Full Text] [PDF]
|
|
|
|
|
|
M. A. Pohl, S. Blumenthal, D. J. Cordonnier, F. De Alvaro, G. DeFerrari, G. Eisner, E. Esmatjes, R. E. Gilbert, L. G. Hunsicker, J. B. L. de Faria, et al. Independent and Additive Impact of Blood Pressure Control and Angiotensin II Receptor Blockade on Renal Outcomes in the Irbesartan Diabetic Nephropathy Trial: Clinical Implications and Limitations J. Am. Soc. Nephrol., October 1, 2005; 16(10): 3027 - 3037. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. M. O'Hare, R. A. Rodriguez, and P. Bacchetti Low Ankle-Brachial Index Associated With Rise in Creatinine Level Over Time: Results From the Atherosclerosis Risk in Communities Study Arch Intern Med, July 11, 2005; 165(13): 1481 - 1485. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. A. Young, W. J. Katon, M. Von Korff, G. E. Simon, E. H. B. Lin, P. S. Ciechanowski, T. Bush, M. Oliver, E. J. Ludman, and E. J. Boyko Racial and Ethnic Differences in Microalbuminuria Prevalence in a Diabetes Population: The Pathways Study J. Am. Soc. Nephrol., January 1, 2005; 16(1): 219 - 228. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T.-J. Hsieh, P. Fustier, C.-C. Wei, S.-L. Zhang, J. G Filep, S.-S. Tang, J. R Ingelfinger, I G. Fantus, P. Hamet, and J. S D Chan Reactive oxygen species blockade and action of insulin on expression of angiotensinogen gene in proximal tubular cells J. Endocrinol., December 1, 2004; 183(3): 535 - 550. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. E. Lok, M. J. Oliver, D. M. Rothwell, and J. E. Hux The growing volume of diabetes-related dialysis: a population based study Nephrol. Dial. Transplant., December 1, 2004; 19(12): 3098 - 3103. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. E. Thomas and T. J. Thekkumkara Glucose Mediates Transcriptional Repression of the Human Angiotensin Type-1 Receptor Gene: Role for a Novel Cis-acting Element Mol. Biol. Cell, October 1, 2004; 15(10): 4347 - 4355. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Miller, A. Rosenbloom, and J. Silverstein Childhood Obesity J. Clin. Endocrinol. Metab., September 1, 2004; 89(9): 4211 - 4218. [Full Text] [PDF]
|
|
|
|
 |
|
 T. Y. Wong, A. Shankar, R. Klein, and B. E.K. Klein Retinal Vessel Diameters and the Incidence of Gross Proteinuria and Renal Insufficiency in People With Type 1 Diabetes Diabetes, January 1, 2004; 53(1): 179 - 184. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Muntner, J. Coresh, N. R. Powe, and M. J. Klag The Contribution of Increased Diabetes Prevalence and Improved Myocardial Infarction and Stroke Survival to the Increase in Treated End-Stage Renal Disease J. Am. Soc. Nephrol., June 1, 2003; 14(6): 1568 - 1577. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Harris, K. Donahue, S. S. Rathore, P. Frame, S. H. Woolf, and K. N. Lohr Screening Adults for Type 2 Diabetes: A Review of the Evidence for the U.S. Preventive Services Task Force Ann Intern Med, February 4, 2003; 138(3): 215 - 229. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. T. Lackland, H. E. Bendall, C. Osmond, B. M. Egan, and D. J. P. Barker Low Birth Weights Contribute to the High Rates of Early-Onset Chronic Renal Failure in the Southeastern United States Arch Intern Med, May 22, 2000; 160(10): 1472 - 1476. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 UK Prospective Diabetes Study Group Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38 BMJ, September 12, 1998; 317(7160): 703 - 713. [Abstract] [Full Text]
|
|
|
|
 |
|
 M. J. Klag, P. K. Whelton, B. L. Randall, J. D. Neaton, F. L. Brancati, C. E. Ford, N. B. Shulman, and J. Stamler Blood Pressure and End-Stage Renal Disease in Men N. Engl. J. Med., January 4, 1996; 334(1): 13 - 18. [Abstract] [Full Text] [PDF]
|
|
Article
